AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 26-50/168
K-RAS GENE-MUTATIONS IN THE DIAGNOSIS OF FINE-NEEDLE ASPIRATES OF PANCREATIC MASSES - PROSPECTIVE-STUDY USING 2 TECHNIQUES WITH DIFFERENT DETECTION LIMITS
Authors: MORA J PUIG P BOADAS J URGELL E MONTSERRAT E LERMA E GONZALEZSASTRE F LLUIS F FARRE A CAPELLA G
Citation: J. Mora et al., K-RAS GENE-MUTATIONS IN THE DIAGNOSIS OF FINE-NEEDLE ASPIRATES OF PANCREATIC MASSES - PROSPECTIVE-STUDY USING 2 TECHNIQUES WITH DIFFERENT DETECTION LIMITS, Clinical chemistry, 44(11), 1998, pp. 2243-2248
CDC25 CELL CYCLE-ACTIVATING PHOSPHATASES AND C-MYC EXPRESSION IN HUMAN NON-HODGKINS-LYMPHOMAS
Authors: HERNANDEZ S HERNANDEZ L BEA S CAZORLA M FERNANDEZ PL NADAL A MUNTANE J MALLOFRE C MONTSERRAT E CARDESA A CAMPO E
Citation: S. Hernandez et al., CDC25 CELL CYCLE-ACTIVATING PHOSPHATASES AND C-MYC EXPRESSION IN HUMAN NON-HODGKINS-LYMPHOMAS, Cancer research, 58(8), 1998, pp. 1762-1767
MANTLE CELL LYMPHOMA - PRESENTING FEATURES, RESPONSE TO THERAPY AND PROGNOSTIC FACTORS
Authors: BOSCH F LOPEZGUILLERMO A CAMPO E RIBERA JM CONDE E PIRIS MA VALLESPI T WOESSNER S MONTSERRAT E
Citation: F. Bosch et al., MANTLE CELL LYMPHOMA - PRESENTING FEATURES, RESPONSE TO THERAPY AND PROGNOSTIC FACTORS, Cancer, 82(3), 1998, pp. 567-575
MYELOFIBROSIS WITH MYELOID METAPLASIA IN YOUNG INDIVIDUALS - DISEASE CHARACTERISTICS, PROGNOSTIC FACTORS AND IDENTIFICATION OF RISK GROUPS
Authors: CERVANTES F BAROSI G DEMORY JL REILLY J GUARNONE R DUPRIEZ B PEREIRA A MONTSERRAT E
Citation: F. Cervantes et al., MYELOFIBROSIS WITH MYELOID METAPLASIA IN YOUNG INDIVIDUALS - DISEASE CHARACTERISTICS, PROGNOSTIC FACTORS AND IDENTIFICATION OF RISK GROUPS, British Journal of Haematology, 102(3), 1998, pp. 684-690
CLINICAL RELEVANCE OF INTERLEUKIN-6 (IL-6) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) SERUM LEVELS IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Authors: BLADE J FILELLA X MONTOTO S BOSCH F MOLINA R COCA F LOPEZGUILLERMO AL CID J BALLESTA AM MONTSERRAT E
Citation: J. Blade et al., CLINICAL RELEVANCE OF INTERLEUKIN-6 (IL-6) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) SERUM LEVELS IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS), British Journal of Haematology, 102(1), 1998, pp. 9-9
PHENOTYPIC CHANGES IN PERIPHERAL-BLOOD NEUTROPHIL GRANULOCYTES (NG) OF HEALTHY DONORS AFTER G-CSF ADMINISTRATION
Authors: ZARCO MA RIBERA JM URBANOISPIZUA A FILELLA X ARRIOLS R MARTINEZ C FELIU E MONTSERRAT E
Citation: Ma. Zarco et al., PHENOTYPIC CHANGES IN PERIPHERAL-BLOOD NEUTROPHIL GRANULOCYTES (NG) OF HEALTHY DONORS AFTER G-CSF ADMINISTRATION, British Journal of Haematology, 102(1), 1998, pp. 87-87
EXPRESSION OR POTENTIALLY ONCOGENIC HIV-8 GENES IN HIV-NEGATIVE, EBV-NEGATIVE PRIMARY EFFUSION LYMPHOMA
Authors: COBO F SOLE M BOSCH F ESTEVE J PINYOL M HERNANDEZ L LOPEZGUILLERMO A RAFEL M RAFFELD M JAFFE ES MONTSERRAT E CAMPO E
Citation: F. Cobo et al., EXPRESSION OR POTENTIALLY ONCOGENIC HIV-8 GENES IN HIV-NEGATIVE, EBV-NEGATIVE PRIMARY EFFUSION LYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 122-122
EXPRESSION OF BETA-1-INTEGRIN (BETA-1-I) ADHESION MOLECULES IN NON-HODGKINS-LYMPHOMA (NHL)
Authors: TEROL MJ LOPEZGUILLERMO A BOSCH F VILLAMOR N CID MC CAMPO E MONTSERRAT E
Citation: Mj. Terol et al., EXPRESSION OF BETA-1-INTEGRIN (BETA-1-I) ADHESION MOLECULES IN NON-HODGKINS-LYMPHOMA (NHL), British Journal of Haematology, 102(1), 1998, pp. 126-126
COLLABORATIVE METAANALYSIS OF RANDOMIZED TRIALS IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
Authors: BINET JL DIGHIERO G CATOVSKY D HANSEN M JAKSIC B KIMBY E MONTSERRAT E RICHARDS S WIERNIK P
Citation: Jl. Binet et al., COLLABORATIVE METAANALYSIS OF RANDOMIZED TRIALS IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), British Journal of Haematology, 102(1), 1998, pp. 277-277
MYELOFIBROSIS WITH MYELOID METAPLASIA (MMM) IN YOUNG INDIVIDUALS - DISEASE CHARACTERISTICS, PROGNOSTIC FACTORS AND IDENTIFICATION OF RISK GROUPS
Authors: CERVANTES F BAROSI G DEMORY JL REILLY J GUARNONE R DUPRIEZ B PEREIRA A MONTSERRAT E
Citation: F. Cervantes et al., MYELOFIBROSIS WITH MYELOID METAPLASIA (MMM) IN YOUNG INDIVIDUALS - DISEASE CHARACTERISTICS, PROGNOSTIC FACTORS AND IDENTIFICATION OF RISK GROUPS, British Journal of Haematology, 102(1), 1998, pp. 283-283
SEVERE VASCULAR COMPLICATIONS IN ESSENTIAL THROMBOCYTHEMIA (ET) - A STUDY OF THE PREDICTIVE FACTORS IN A SERIES OF 148 PATIENTS
Authors: CERVANTES F BESSES C PEREIRA A FLORENSA L SOLE F HERNANDEZBOLUDA JC WOESSNER S SANSSABRAFEN J ROZMAN C MONTSERRAT E
Citation: F. Cervantes et al., SEVERE VASCULAR COMPLICATIONS IN ESSENTIAL THROMBOCYTHEMIA (ET) - A STUDY OF THE PREDICTIVE FACTORS IN A SERIES OF 148 PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 310-310
IN-VITRO CYTOTOXICITY OF PURINE ANALOGS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: RAFEL M COLOMER D BOSCH F BELLOSILLO B COBO F VILLAMOR N MONTSERRAT E
Citation: M. Rafel et al., IN-VITRO CYTOTOXICITY OF PURINE ANALOGS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 330-330
LYMPHOID BLAST CRISIS OF CHRONIC MYELOID-LEUKEMIA IS ASSOCIATED WITH DISTINCT CLINICOHAEMATOLOGICAL FEATURES
Authors: CERVANTES F VILLAMOR N ESTEVE J MONTOTO S RIVES S ROZMAN C MONTSERRAT E
Citation: F. Cervantes et al., LYMPHOID BLAST CRISIS OF CHRONIC MYELOID-LEUKEMIA IS ASSOCIATED WITH DISTINCT CLINICOHAEMATOLOGICAL FEATURES, British Journal of Haematology, 100(1), 1998, pp. 123-128
ASPIRIN AND SALICYLATE INDUCE APOPTOSIS AND ACTIVATION OF CASPASES INB-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS
Authors: BELLOSILLO B PIQUE M BARRAGAN M CASTANO E VILLAMOR N COLOMER D MONTSERRAT E PONS G GIL J
Citation: B. Bellosillo et al., ASPIRIN AND SALICYLATE INDUCE APOPTOSIS AND ACTIVATION OF CASPASES INB-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS, Blood, 92(4), 1998, pp. 1406-1414
P16(INK4A) GENE INACTIVATION BY DELETIONS, MUTATIONS, AND HYPERMETHYLATION IS ASSOCIATED WITH TRANSFORMED AND AGGRESSIVE VARIANTS OF NON-HODGKINS-LYMPHOMAS
Authors: PINYOL M COBO F BEA S JARES P NAYACH I FERNANDEZ PL MONTSERRAT E CARDESA A CAMPO E
Citation: M. Pinyol et al., P16(INK4A) GENE INACTIVATION BY DELETIONS, MUTATIONS, AND HYPERMETHYLATION IS ASSOCIATED WITH TRANSFORMED AND AGGRESSIVE VARIANTS OF NON-HODGKINS-LYMPHOMAS, Blood, 91(8), 1998, pp. 2977-2984
RENAL-FAILURE IN MULTIPLE-MYELOMA - PRESENTING FEATURES AND PREDICTORS OF OUTCOME IN 94 PATIENTS FROM A SINGLE INSTITUTION
Authors: BLADE J FERNANDEZLLAMA P BOSCH F MONTOLIU J LENS XM MONTOTO S CASES A DARNELL A ROZMAN C MONTSERRAT E
Citation: J. Blade et al., RENAL-FAILURE IN MULTIPLE-MYELOMA - PRESENTING FEATURES AND PREDICTORS OF OUTCOME IN 94 PATIENTS FROM A SINGLE INSTITUTION, Archives of internal medicine, 158(17), 1998, pp. 1889-1893
CUTANEOUS INVOLVEMENT AS THE FIRST MANIFESTATION IN A CASE OF T-CELL PROLYMPHOCYTIC LEUKEMIA
Authors: SERRA A ESTRACH MT MARTI R VILLAMOR N RAFEL M MONTSERRAT E
Citation: A. Serra et al., CUTANEOUS INVOLVEMENT AS THE FIRST MANIFESTATION IN A CASE OF T-CELL PROLYMPHOCYTIC LEUKEMIA, Acta dermato-venereologica, 78(3), 1998, pp. 198-200
NEW THERAPEUTIC ISSUES IN CLL
Authors: MONTSERRAT E
Citation: E. Montserrat, NEW THERAPEUTIC ISSUES IN CLL, HEM CELL TH, 39, 1997, pp. 45-49
TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - CURRENT STATUS ANDFUTURE PERSPECTIVES
Authors: MONTSERRAT E BOSCH F ROZMAN C
Citation: E. Montserrat et al., TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - CURRENT STATUS ANDFUTURE PERSPECTIVES, Journal of internal medicine, 242, 1997, pp. 63-67
B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - RECENT PROGRESS IN BIOLOGY, DIAGNOSIS, AND THERAPY
Authors: MONTSERRAT E BOSCH F ROZMAN C
Citation: E. Montserrat et al., B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - RECENT PROGRESS IN BIOLOGY, DIAGNOSIS, AND THERAPY, Annals of oncology, 8, 1997, pp. 93-101
ABOUT THE PROGNOSTIC VALUE OF BONE-MARROW HISTOPATHOLOGICAL PATTERNS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: ROZMAN C BRUGUES R MONTSERRAT E
Citation: C. Rozman et al., ABOUT THE PROGNOSTIC VALUE OF BONE-MARROW HISTOPATHOLOGICAL PATTERNS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, European journal of haematology, 59(1), 1997, pp. 61-62
CHRONIC LYMPHOCYTIC-LEUKEMIA - A CHANGING NATURAL-HISTORY
Authors: ROZMAN C BOSCH F MONTSERRAT E
Citation: C. Rozman et al., CHRONIC LYMPHOCYTIC-LEUKEMIA - A CHANGING NATURAL-HISTORY, Leukemia, 11(6), 1997, pp. 775-778
SIMULTANEOUS OCCURRENCE OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA AND CHRONIC MYELOID-LEUKEMIA WITH FURTHER EVOLUTION TO LYMPHOID BLAST CRISIS
Authors: ESTEVE J CERVANTES F RIVES S ROZMAN M ZARCO MA MONTSERRAT E
Citation: J. Esteve et al., SIMULTANEOUS OCCURRENCE OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA AND CHRONIC MYELOID-LEUKEMIA WITH FURTHER EVOLUTION TO LYMPHOID BLAST CRISIS, Haematologica, 82(5), 1997, pp. 596-599
ESTIMATION OF BONE-MARROW CELLULARITY BY MEANS OF VERTEBRAL MAGNETIC-RESONANCE
Authors: ROZMAN M MERCADER JM AGUILAR JL MONTSERRAT E ROZMAN C
Citation: M. Rozman et al., ESTIMATION OF BONE-MARROW CELLULARITY BY MEANS OF VERTEBRAL MAGNETIC-RESONANCE, Haematologica, 82(2), 1997, pp. 166-170
PLATELETS FROM PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA SUPPORT INCREASED TISSUE FACTOR-INDUCED THROMBIN GENERATION
Authors: REVERTER JC PERALES M MARIN P TASSIES D VILLAMOR N PINO M MONTEAGUDO J ESCOLAR G MONTSERRAT E ORDINAS A
Citation: Jc. Reverter et al., PLATELETS FROM PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA SUPPORT INCREASED TISSUE FACTOR-INDUCED THROMBIN GENERATION, Thrombosis and haemostasis, 1997, pp. 2359-2359
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>